Galiximab (IDEC 114) 是一种靶向CD80抗原的免疫球蛋白 G1 (IgG1) 单抗。Galiximab 的可变区域是灵长类猴，恒定区域是人类。Galiximab 可用于 B 细胞淋巴瘤的研究。
| 生物活性 | Galiximab (IDEC 114) is a primatizedimmunoglobulin G1(IgG1) lambda monoclonal antibody directed against theCD80antigen. Galiximab has variable regions are primatized (cynomologous monkeys), and the constant regions are human. Galiximab can be used in research of B-cell lymphoma[1]. |
| IC50& Target | |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
